News
Wegovy is a once-weekly injection ... calories you should be eating per day to reach your weight loss goals with the Calorie Deficit Calculator. Some foods may aggravate these side effects more ...
One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia ...
Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...
The MUSC Weight Management Center (WMC) is casting a lifeline to plus-sized individuals at wit's end with their apple cider ...
twice the share for Wegovy. Prescribing has shifted: in the first quarter of 2025 Zepbound made up 60% of total weight-loss prescriptions in America, and 75% of new ones. Chart: The Economist ...
Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...
Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...
14d
Oprah Daily on MSNDoes Combining Hormone Therapy and a GLP-1 Boost Your Menopausal Weight Loss? Here's What the Research SaysMenopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...
7d
Zacks Investment Research on MSNNovo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...
American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results